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Sutterella species have been frequently associated with human diseases, such as
autism, Down syndrome, and inflammatory bowel disease (IBD), but the impact of
these bacteria on health still remains unclear. Especially the interactions of Sutterella
spp. with the host are largely unknown, despite of the species being highly prevalent.
In this study, we addressed the interaction of three known species of Sutterella with
the intestinal epithelium and examined their adhesion properties, the effect on intestinal
barrier function and the pro-inflammatory capacity in vitro. We also studied the relative
abundance and prevalence of the genus Sutterella and Sutterella wadsworthensis
in intestinal biopsies of healthy individuals and patients with celiac disease (CeD) or
IBD. Our results show that Sutterella spp. are abundant in the duodenum of healthy
adults with a decreasing gradient toward the colon. No difference was detected
in the prevalence of Sutterella between the pediatric IBD or CeD patients and the
healthy controls. Sutterella parvirubra adhered better than the two other Sutterella
spp. to differentiated Caco-2 cells and was capable of decreasing the adherence of
S. wadsworthensis, which preferably bound to mucus and human extracellular matrix
proteins. Furthermore, only S. wadsworthensis induced an interleukin-8 production in
enterocytes, which could be due to different lipopolysaccharide structures between
the species. However, its pro-inflammatory activity was modest as compared to
non-pathogenic Escherichia coli. Sutterella spp. had no effect on the enterocyte
monolayer integrity in vitro. Our findings indicate that the members of genus Sutterella
are widely prevalent commensals with mild pro-inflammatory capacity in the human
gastrointestinal tract and do not contribute significantly to the disrupted epithelial
homeostasis associated with microbiota dysbiosis and increase of Proteobacteria. The
ability of Sutterella spp. to adhere to intestinal epithelial cells indicate that they may have
an immunomodulatory role.
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INTRODUCTION
The three known species of the genus Sutterella, consisting of
Sutterella wadsworthensis, Sutterella parvirubra, and Sutterella
stercoricanis, have been isolated from the human gastrointestinal
(GI) tract and canine feces (Wexler et al., 1996; Greetham
et al., 2004; Sakon et al., 2008). Sutterella spp., belonging to
Betaproteobacteria, are Gram-negative, non-spore-forming rods
that grow in a microaerophilic atmosphere or under anaerobic
conditions (Wexler, 2005). They are notably resistant to human
bile acids, which may account for their survival in the biliary
tract and bowel. The role of Sutterella spp. as part of the human
microbiota is largely unexplored with published reports being
partly controversial. The lack of knowledge is rather surprising
since Sutterella spp. have been reported to be highly prevalent
and abundant in the intestinal mucosa of humans (Mukhopadhya
et al., 2011; Cheng et al., 2013; Hansen et al., 2013). Firstly,
S. wadsworthensis has been detected in 86 and 71% of adults
and children, respectively (Mukhopadhya et al., 2011; Hansen
et al., 2013). Secondly, the average abundance of Sutterella spp.
has been found to be as high as 19% of the total microbiota in
the duodenal mucosa of both celiac disease (CeD) and healthy
children (Cheng et al., 2013).
Although Sutterella spp. have been suspected to play a
part in the pathogenesis of inflammatory bowel disease (IBD;
Mangin et al., 2004; Gophna et al., 2006; Lavelle et al., 2015),
in other studies no difference in the prevalence of Sutterella
spp. has been found between the IBD patients and the healthy
subjects (Mukhopadhya et al., 2011; Hansen et al., 2013).
Furthermore, Sutterella spp. have been associated with autism,
Down syndrome, and metabolic syndrome (Williams et al., 2012;
Wang et al., 2013; Biagi et al., 2014; Lim et al., 2016). Half of
the children with autism and GI dysfunction were Sutterella-
positive with a predominance of either S. wadsworthensis or
S. stercoricanis, whereas these species were not detected in
the control group with only GI dysfunction (Williams et al.,
2012). The abundance varied between 2 and 7% of total
bacteria in the ileum and cecum. However, in another study
no significant difference in the microbial composition, including
the abundance of Sutterella, was observed between the autistic
pediatric subjects with or without functional GI disorders
compared to their siblings (Son et al., 2015). Thus, the results
concerning the association of Sutterella spp. with human diseases
are controversary and their possible role in the pathology and
interaction with the host are still unknown.
Commensals form a diverse and balanced bacterial
community, which colonizes the mammalian mucosal surfaces
without causing harm to the host. As part of the host–microbiota
mutualism, commensal bacteria shape the development of
both innate and adaptive immune systems and promote
immunological tolerance in the host (Clemente et al., 2012;
Nicholson et al., 2012). Various pattern recognition receptors
on intestinal epithelial cells (IECs), such as Toll-like receptors
(TLRs), recognize microorganism-associated molecular patterns
(MAMPs) expressed by bacteria (Round et al., 2011; Bron
et al., 2012). A major MAMP produced by Gram-negative
bacteria on their cell surface is lipopolysaccharide (LPS), which
activates TLR4 signaling, thus triggering inflammatory cascades
(Miller et al., 2005). IECs can sense MAMPs and consequently
act as transmitters of immunomodulatory signals from the
microbiota to immune cells in lamina propria (LP), where most
of the immune cells do not have direct contact with bacteria
(de Kivit et al., 2011; Ivanov and Honda, 2012). Specifically,
gut commensals are needed to induce the differentiation of
Th17 cells in LP (Gaboriau-Routhiau et al., 2009; Ivanov et al.,
2009; Atarashi et al., 2015) and importantly, this stimulation is
dependent on the adhesion of bacteria to IECs (Atarashi et al.,
2015).
The interaction between a balanced, stable microbiota and
the mucosal immune system maintains intestinal homeostasis,
which, however, can be easily disturbed by alterations in the
microbial community leading to pro-inflammatory immune
responses. This imbalance in the composition of gut microbiota
(dysbiosis) is generally characterized by a decrease in the
abundance of Firmicutes and an increase of Proteobacteria,
the phylum that also contains Sutterella spp. (Mukhopadhya
et al., 2012; Shin et al., 2015). In a healthy GI tract the relative
abundance of Proteobacteria varies between 2 and 5%, whereas in
metabolic disorders and intestinal inflammation the proportion
can be up to 15% (Fei and Zhao, 2013; Gevers et al., 2014;
Walujkar et al., 2014; Lavelle et al., 2015; Shin et al., 2015).
Increase in the amount of Proteobacteria may contribute to non-
specific mucosal inflammation due to LPS as a potent stimulator
and possibly predispose the host to a chronic inflammatory
disease (Round and Mazmanian, 2009). Therefore, it is important
to determine the interactions and pro-inflammatory capacity
of different representative taxa of Proteobacteria and establish
in what scale they play a part in the microbiota dysbiosis and
deleterious effects associated with it.
The epithelial interactions and the role of Sutterella spp.
in the human GI tract still remain unclear. In this study, we
addressed the adhesive and pro-inflammatory properties of three
known Sutterella spp. using various in vitro models, including the
adhesion to intestinal epithelial cell lines, mucus and extracellular
matrix (ECM) proteins, as well as their effect on the epithelial
barrier function and interleukin-8 (IL-8) release in enterocytes. In
addition, we investigated the relative abundance of these species
in different parts of the human intestine and the prevalence in
pediatric patients with CeD or IBD.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Sutterella wadsworthensis (DSM 14016 = ATCC 51579, type
strain), S. parvirubra (DSM 19354=YIT 11816T , type strain) and
S. stercoricanis (DSM 17807 = CCUG 47620T , type strain) were
obtained from German Collection of Microorganisms and Cell
Cultures (DSMZ) and grown on Gifu anaerobic medium (GAM;
Nissui Pharmaceutical Co., Ltd., Japan) agar for 2 days at 37◦C
in an anaerobic incubator (Concept Plus anaerobic workstation,
Ruskinn Technology Ltd., UK) containing 85% N2, 10% CO2,
and 5% H2. Bacteroides fragilis E-022248T received from the
VTT Culture Collection (VTT Technical Research Center of
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Finland) was grown under anaerobic conditions for 2 days at
37◦C on Brucella agar with hemin and vitamin K (Fluka, USA)
along with 5% defibrinated sheep blood (Bio Karjalohja Oy,
Finland). Escherichia coli K12-derived TOP10 cells (Invitrogen,
USA) were aerobically cultivated in Luria–Bertani broth (Becton
Dickinson, USA) overnight at 37◦C with agitation (220 rpm).
For adhesion experiments, Sutterella spp. were grown on GAM
agar supplemented with 10 µl ml−1 of [6′-3H]thymidine (17,6
Ci mmol−1, Perkin Elmer, USA) to metabolically radiolabel the
cells.
Epithelial Cell Lines
The human colonic epithelial cell lines Caco-2 (ACC 169) and
HT-29 (ACC 299) were obtained from DSMZ and grown at
37◦C in an incubator under oxic atmosphere with 5% CO2. Cells
were passaged after reaching 80% confluence using HyClone
HyQTase (GE Healthcare Life Sciences, USA) to detach the cells.
Passage numbers 5–28 were used in the experiments. Caco-2
cells were grown in RPMI 1640 medium (Sigma-Aldrich, USA)
supplemented with heat-inactivated (30 min at 56◦C) fetal bovine
serum (FBS, 20%; Integro B.V., Netherlands), non-essential
amino acids (1%; Lonza, Belgium), 15 mM HEPES (Lonza,
Belgium), 100 U ml−1 penicillin and streptomycin (PEST; Lonza,
Belgium), and 2 mM L-glutamine (Lonza, Belgium). HT-29
cells were cultivated in McCoy 5A (Lonza, Belgium) medium
containing 10% FBS and 100 U ml−1 PEST. For adhesion and
ELISA assays, 10,000 Caco-2 or HT-29 cells per well were seeded
onto 96-well microplates.
Isolation of Human Intestinal Mucus
Human colonic mucus was isolated from a healthy piece of
tissue from a colorectal cancer patient as previously described
(Vesterlund et al., 2005). The use of human intestinal mucus for
the adhesion assays was approved by the ethical committee of
the Hospital District of Southwest Finland. A written informed
consent was obtained from all patients who donated tissue.
Bacterial DNA Extraction
Sutterella spp. and B. fragilis bacterial masses were collected
from agar plates with an inoculation loop and suspended to lysis
buffer. E. coli broth culture was centrifuged (5,000 × g, 5 min) to
pellet the cells and DNA was extracted with QIAamp DNA mini
kit (Qiagen, UK) according to the manufacturer’s instructions.
DNA concentrations were measured using NanoDrop ND-1000
spectrophotometer (NanoDrop Technologies, USA).
Study Subjects and Clinical Samples
Intestinal mucosal biopsies were obtained from adult volunteers
recruited at the Department of Gastroenterology at Helsinki
University Central Hospital (5 males and 17 females, mean age
65 years), who underwent diagnostic nasogastroduodenoscopy
or/and colonoscopy and were found to have a healthy intestine
(Supplementary Table S1). Rectal biopsies were also obtained
from adult patients (four males and seven females, mean
age 57 years) who had been successfully treated with a fecal
microbiota transplantation (FMT) for recurrent Clostridium
difficile infection (rCDI; Supplementary Table S1; Satokari et al.,
2015). Biopsies were collected in sterile tubes and stored at
−80◦C until the DNA extraction. DNA from the biopsy samples
was extracted as described previously (Kalliomaki et al., 2012),
involving a mechanical lysis step for the efficient recovery of
bacterial DNA. The study was approved by the Ethics Committee
of Hospital District of Helsinki and Uusimaa (HUS), Finland.
All healthy adult volunteers who donated biopsies signed an
informed consent.
Intestinal mucosal biopsies from pediatric patients were
obtained from our previous studies (Kalliomaki et al., 2012, 2014)
or newly collected at the Department of Pediatrics in Turku
University Central Hospital. DNA was isolated as mentioned
above. The study subjects included healthy controls (n = 33)
and patients with CeD (n = 9), Crohn’s disease (CD, n = 14),
and ulcerative colitis (UC, n = 25). The age and gender of
the subjects, the location of biopsies, and disease activity are
compiled in Supplementary Table S2. The study was approved
by the Ethics Committee of the Hospital District of Southwest
Finland. A written informed consent was obtained from all of the
study patients and/or their parents.
Quantitative Real-Time PCR Assays
Quantification of Sutterella spp. and S. wadsworthensis from
the intestinal biopsy samples was carried out using previously
described quantitative real-time PCR (qPCR) assays (Suzuki and
Giovannoni, 1996; Paliy et al., 2009; Mukhopadhya et al., 2011;
Williams et al., 2012). The standard DNA for Sutterella genus
assay was prepared from amplified 260-bp region between V6
and V8 of the 16S rRNA gene from S. wadsworthensis (ATCC
51579). Primers were SuttFor (5′-CGC GAA AAA CCT TAC
CTA GCC-3′) and SuttRev (5′-GAC GTG TGA GGC CCT AGC
C-3′) (Williams et al., 2012). For S. wadsworthensis specific assay
standard, a 555-bp long PCR-fragment of the 16S rRNA gene
from S. wadsworthensis was amplified using forward primer SWF
(5′-GAC GAA AAG GGA TGC GAT AA-3′) and reverse primer
SWR (5′-CTG GCA TGT CAA GGC TAG GT-3′) (Mukhopadhya
et al., 2011). The standard DNA for universal assay was produced
by amplifying a 310-bp long fragment of the 16S rRNA gene
from Prevotella melaninogenica using universal bacterial primers
27F-DegL (5′-AGR GTT YGA TYM TGG CTC AG-3′) (Paliy
et al., 2009) and 338R (5′-TGC TGC CTC CCG TAG GAG T-
3′) (Suzuki and Giovannoni, 1996). All the PCR-fragments were
purified using QIAquick PCR purification kit (Qiagen, Germany)
and DNA concentrations were measured with NanoDrop
ND-1000 spectrophotometer (NanoDrop Technologies, USA).
Based on the calculated molecular mass of the amplicon, the
number of copies per microliter was calculated for each PCR-
fragment to create six-point standard curves using 10-fold serial
dilutions (106–101 copies). Samples were analyzed in triplicate
using a 96-well plate format. Amplification and detection of
DNA by qPCR were performed with Mx3005P Real-time PCR
System (Stratagene, USA) and the results were analyzed with
MxPro Real-time PCR Software version 4.1 (Stratagene, USA).
AmpliTaq Gold DNA Polymerase kit (Applied Biosystems,
Life Technologies, USA) and SYBR Green chemistry were
used. Each 25 µl reaction contained 25 ng of biopsy DNA,
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0.5 µM of each primers, 0.1 mM deoxynucleoside triphosphate
(dNTP) mix (Thermo Scientific, USA), 10 mM Tris–HCl (pH
8.3), 50 mM KCl, 3 mM MgCl2, 1:75,000 dilution of SYBR
Green I (Lonza Biosciences, Switzerland), and 0.025 U µl−1
AmpliTaq Gold DNA Polymerase. The thermocycling parameters
consisted of an initial denaturation step at 95◦C for 10 min,
followed by 45 cycles of 95◦C (30 s), 58◦C (1 min), and 72◦C
(1 min).
Adhesion Assays to Cell Lines, Mucus,
and ECM Proteins
The adherence of Sutterella spp. to Caco-2 and HT-29 cell
lines (3, 8, and 21 days post-plating), mucus, and ECM
proteins was studied as described previously (Kainulainen et al.,
2013; Reunanen et al., 2015). Briefly, the Caco-2 and HT-29
cell lines were seeded on a 96-well tissue culture plate with
10,000 cells well−1. Human mucus preparations collected from
several patients were pooled evenly and diluted in phosphate-
buffered saline (PBS). Porcine mucus (Sigma-Aldrich) and
human ECM proteins, including collagens I (Sigma-Aldrich,
USA) and IV (Sigma-Aldrich), laminin (Sigma-Aldrich), and
fibronectin (Calbiochem, USA), were diluted in PBS. Bovine
serum albumin (BSA; Sigma-Aldrich) and fetuin (Sigma-Aldrich)
were used as controls for non-specific binding. Human and
porcine mucus (50 µg well−1 in PBS) and ECM proteins
(2.5 pmol well−1 in PBS) were incubated on Maxisorp microtiter
plates overnight at 4◦C and blocked with 0.5% (w/v) BSA in
PBS for 1 h prior to the adhesion assay. Four technical replicates
(parallel wells) were used in each experiment. [3H]Thymidine-
labeled S. wadsworthensis, S. parvirubra, and S. stercoricanis
cells were collected from agar plates to PBS, washed with an
appropriate medium (McCoy 5A for HT-29 cells and RPMI
1640 for Caco-2) without supplements or PBS and adjusted
to OD600 nm 0.25, which corresponded to approximately
108 cells ml−1. The bacterial suspensions were incubated for 1 h
on mucus and ECM proteins at 37◦C or on the cell lines at
37◦C in a CO2 incubator, followed by washing three times to
remove the non-adherent cells. Bound bacteria were lysed with
1% SDS–0.1 M NaOH and radioactivity was measured with a
liquid scintillator (Wallac Winspectral 1414, Perkin-Elmer, USA).
The percentage of adhered bacteria was calculated relative to
the radioactivity of the bacterial suspension initially added to
the wells. The adhesion to ECM proteins was also calculated as
percentages and compared to the level of background binding
(BSA).
Displacement, Competition, and
Exclusion Assays
The displacement, exclusion, and competition assays with
S. parvirubra and radiolabeled S. wadsworthensis were performed
as previously described with minor modifications (Vesterlund
et al., 2006). The bacteria were adjusted to OD600 nm 0.25.
Four technical replicates (parallel wells) were used in each
experiment. Eight days post-plating Caco-2 and HT-29 cells
(10,000 cells well−1) were fixed with 4% paraformaldehyde
(Sigma-Aldrich, USA) for 2 h at room temperature before
the assay. The cell monolayers were fixed due to multiple,
repeated washing steps, which otherwise cause detaching of the
non-fixed cells. In the competition assays, both species were
incubated with the enterocytes together, whereas in the exclusion
assays S. parvirubra was incubated first, then washed away
and followed by S. wadsworthensis. In the displacement assays
S. wadsworthensis adhered first followed by S. parvirubra. The
percentage of adhered bacteria was calculated relative to the
radioactivity of the bacterial suspension initially added to the
wells and the non-competitive situation with similar washing
steps is shown as the control.
TER Assay
The impact of Sutterella spp. on transepithelial electrical
resistance (TER) of Caco-2 monolayer was determined as
previously described (Kainulainen et al., 2015; Reunanen et al.,
2015). The Caco-2 cell line is a suitable model for TER assays,
because Caco-2 cells undergo enterocytic differentiation as well as
express intercellular junctional complexes and, therefore, changes
in TER can be measured as a response to external stimuli
(Hidalgo et al., 1989; Klingberg et al., 2005; Hsieh et al., 2015).
E. coli TOP10 was included in the experiment as a negative
control, since the bacterium has been shown to adversely affect
the monolayer integrity (Reunanen et al., 2015). B. fragilis,
on the other hand, increases TER of epithelial cells and was
used as a positive control (Reunanen et al., 2015). The blank
resistance (measurement at time point 0) was subtracted from the
measurements made after 24 and 48 h of incubation, and the unit
area resistance (cm2) was calculated by multiplying the tissue
resistance values by surface area of the filter membrane.
IL-8 Production in HT-29 Cells
IL-8 assays were only performed using the HT-29 cell line,
because Caco-2 cells are known to be unresponsive to LPS
stimulation possibly due to defects in TLR4 signaling (Funda
et al., 2001; Van De Walle et al., 2010; Hsu et al., 2011).
The measurement of IL-8 response in 8-day-old HT-29 cells
by Sutterella spp., E. coli and B. fragilis was carried out as
previously described (Kainulainen et al., 2013). In brief, the
bacterial suspensions were washed with McCoy 5A medium
supplemented with 10% FBS and adjusted to OD600 nm 0.25.
Bacteria were diluted to 1:10, 1:100, and 1:1,000 and incubated
on the HT-29 cells for 3 h at 37◦C in a CO2 incubator. Three
technical replicates (parallel wells) were used in each experiment.
OptEIA Human IL-8 ELISA kit (BD Biosciences, USA) was
used according to the manufacturer’s instructions to measure the
concentration of the chemokine in the culture media. To prepare
the LPS preparations, bacteria were adjusted to OD600 nm 0.25
and 500 µl of the suspension was centrifuged (9,000× g, 10 min.)
to pellet the cells. The pellets were suspended to 20 µl of lysis
buffer (2% SDS, 50 mM Tris–HCL) and heated to 100◦C for
10 min. After cooling, proteinase K (Thermo Scientific, USA) was
added to the cell lysates with a final concentration of 0.5 mg ml−1
and incubated at 60◦C for 2 h. The lysates were once again heated
to 100◦C to inactive proteinase K, then 450 µl of McCoy 5A
medium supplemented with 10% heat-inactivated FBS was added
and the lysates were diluted to 1:10–1:10,000.
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Silver Staining of Sutterella LPS and
Western Blotting
The LPS structures of Sutterella spp. and E. coli TOP10 were
visualized with silver staining as previously described (Tsai and
Frasch, 1982). Prior to SDS-PAGE the bacterial pellets were
suspended to loading buffer and heated to 100◦C for 5 min.
The whole-cell lysates were treated with proteinase K (final
concentration 0.5 mg ml−1) at 60◦C for 2 h, followed by heat-
inactivation of the enzyme. The samples were run in SDS-PAGE
under denaturing conditions on a gradient gel (4–15%, Mini-
Protean TGX, Bio-Rad, USA) and silver stained. Proteinase
K treatment reduces bacterial proteins to small peptides but
leaves the carbohydrate LPS unaffected, which then can be
detected due to periodate-sensitive cis-glycols in the core and
the side-chains of LPS (Kropinski et al., 1986). The LPS chains
that have the same number of sugar repeats co-migrate and
form a band. The whole-cell lysates mentioned above were
also analyzed with Western blotting using a rabbit polyclonal
antiserum against E. coli LPS (1:10,000 dilution; Bioss Inc., USA).
Briefly, the bacterial pellets were run in SDS-PAGE as explained
above without the proteinase K treatment and blotted onto
polyvinylidene difluoride Immobilon P membranes (Millipore,
USA). After the E. coli LPS antiserum, the membrane was
incubated with 1:100,000 diluted HRP-conjugated goat anti-
rabbit IgG secondary antibody (Bio-Rad, USA). Amersham
ECL Advance Western blotting detection kit (GE Healthcare
Bio-Sciences, UK) was used according to the manufacturer’s
instructions.
Statistical Analysis
All the experiments were done using three to four technical
replicates depending on the assay and repeated two to three
times (biological replicates) to confirm the results. Different
cultures of bacteria and different passages of cell lines were used
in the separate experiments. The following tests were used to
compare samples within an experiment. A two-sample t-test was
used to determine significant differences as compared to the
control. Homoscedasticity testing was performed with Levene’s
test to identify equal or unequal variances. A paired-sample t-test
was used for pre- and post-FMT samples. Statistical differences
between the samples were tested with one-way analysis of
variance using a Bonferroni post hoc. All statistical analyses
were carried out with IBM SPSS Statistics program version 21.0
(IBM Corporation, USA). A p-value of <0.05 was considered
statistically significant.
RESULTS
A Decreasing Gradient of Sutterella spp.
Abundance along the GI Tract
In order to assess the amount of Sutterella spp. in the different
parts of a healthy intestine, mucosal biopsies from duodenum,
ileum, and rectum were analyzed with Sutterella-specific and
universal qPCR assays. The results were calculated as a relative
proportion of Sutterella spp. compared to all bacteria (Figure 1).
FIGURE 1 | Relative proportion of Sutterella spp. (% of all bacteria) in
different parts of the intestinal mucosa (duodenum, ileum, rectum) in
healthy adults and in patients pre- and post-FMT. Duodenum (n = 17),
ileum (n = 6), and rectum (n = 5) biopsies were obtained from the healthy
subjects. Other rectum samples (n = 11) were collected from the patients who
had undergone a successful fecal microbiota transplantation (FMT) for
recurrent Clostridium difficile infection (rCDI). Biopsies obtained from the rCDI
patients were collected pre-FMT and 1 month after FMT. A circle and an
asterisk indicate outliers greater than 1.5 and 3 times the interquartile range,
respectively.
Adult patients who underwent successfully the FMT therapy for a
rCDI were also included in the study and rectal samples both pre-
and post-FMT were analyzed. We observed a decreasing gradient
of Sutterella spp. along the GI tract from the small intestine
to the large bowel. The relative abundance of Sutterella in the
duodenum and ileum was significantly higher (p = 0.005) as
compared to the rectum, while the percentage of these species of
the whole duodenal microbiota seemed to vary greatly between
individuals. The pre- and post-FMT samples of rCDI patients
(p = 0.443) or the samples from rCDI patients and other study
subjects did not differ in their Sutterella abundance (p = 0.107;
Figure 1). A gradient in the relative abundance of Sutterella
spp. along the GI tract was observed also at individual level
in the case of one subject, from whom biopsies of all three
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intestinal locations were obtained. In these samples Sutterella
spp. constituted 1.3, 0.3, and 0.2% of the total microbiota in the
duodenum, ileum, and rectum, respectively.
No Difference in Sutterella Prevalence
between Pediatric CeD and IBD Patients
and Healthy Children
Next, we studied whether Sutterella spp. and specifically
S. wadsworthensis are differently present in the duodenum or
colon of pediatric patients with CeD or IBD compared to the
healthy controls. The 16S rRNA gene copy numbers in these
samples were too low for reliable quantitation and, therefore,
only qualitative analysis could be performed. The PCR analysis
showed that Sutterella spp. were present in half of healthy
children’s duodenum and in six out of nine CeD patients
(p = 0.622; Table 1). Surprisingly, S. wadsworthensis was not
detected in the duodenal biopsies of either group. The biopsies
from pediatric UC or CD patients and the controls were obtained
from different parts of the colon (Supplementary Table S2).
The presence of Sutterella spp. was identified in >80% of the
patients in all three groups (p= 1.000), whereas the prevalence of
S. wadsworthensis was 29–40% (p = 0.799). Furthermore, there
was no statistical difference in the prevalence of Sutterella spp.
or S. wadsworthensis when comparing the UC and CD patients
and the healthy controls or depending on the intestinal biopsy
location.
Sutterella wadsworthensis Shows the
Highest Adhesion to Mucus and
Extracellular Matrix Proteins
We examined the adherence of S. wadsworthensis, S. parvirubra,
and S. stercoricanis to immobilized human and porcine mucus,
as well as to ECM proteins, including type I and IV
collagens, laminin, and fibronectin. The adherence ability of
S. wadsworthensis to porcine mucus was better compared to the
other two species (Figure 2A). In fact, S. parvirubra did not bind
mucus, since less than 1% of the added cells had adhered which
is considered to be non-specific background binding. The same
differences between S. wadsworthensis and the other species were
also observed in the adhesion to human mucus (Figure 2A).
TABLE 1 | The prevalence of Sutterella spp. and S. wadsworthensis in the
intestinal mucosa of the pediatric subjects.
Studied subjects
Sutterella spp. S. wadsworthensis
Duodenum
Healthy controls 3/6 ND
Celiac disease 6/9 ND
Colon
Healthy controls 22/27 9/27
Ulcerative colitis 21/25 10/25
Crohn’s disease 12/14 4/14
ND, not detected.
Sutterella spp. showed no difference between human and porcine
mucus binding. When studying the adherence of these bacteria to
ECM proteins, fetuin as a highly glycosylated protein and BSA as
a non-glycosylated protein were included in the assay as controls.
S. wadsworthensis showed significantly higher adhesion to
laminin, collagen I, and fibronectin compared to the background-
level (BSA; Figure 2B). Moreover, its adherence to BSA was
2.3%, whereas the same adhesion ratios for S. parvirubra and
S. stercoricanis were merely 0.8 and 1.5%, respectively (data not
shown). S. parvirubra could only bind to laminin and collagen I,
and S. stercoricanis to collagens I and IV (Figure 2B).
Sutterella parvirubra Adheres Best to
Differentiated Enterocytes and Can
Displace S. wadsworthensis
To compare the adhesion capability of Sutterella spp. to IECs, we
used the Caco-2 and HT-29 cell lines as models of enterocytes.
Caco-2 cells start to differentiate 5–7 days post-plating and
both cell lines lack the mucus layer covering the intestine. Cells
at three different growth stages were included in the assays:
undifferentiated (3 days post-plating) as well as 8- and 21
(partially and fully differentiated)-day-old cells (Park et al., 2015).
HT-29 cells were grown similarly for comparison, although they
do not differentiate. In general, Sutterella spp. adhered equally
well to both cell lines. The adherence level of S. parvirubra
and S. stercoricanis was lower to the undifferentiated Caco-2
cells (3 days; Figure 3). Interestingly, S. parvirubra adhered
significantly better to 8- and 21-day-old Caco-2 cells compared
to the other two species. There was no difference in the
adhesion of all three species to HT-29 cells except S. parvirubra
adhered better than S. stercoricanis to 3-day-old cells. In the
displacement, exclusion, and competition assays, the effect of
S. parvirubra on the adherence of S. wadsworthensis was tested
using 8-day-old cell lines. The adhesion was significantly lowered
(p < 0.001) to 55 and 52% in competition to Caco-2 and
HT-29 cells, respectively (Table 2). Furthermore, displacement
by S. parvirubra reduced the binding of S. wadsworthensis
to both enterocyte lines (p < 0.05) but the effect was more
profound in Caco-2 cells (73%). The preliminary results on
the capability of S. parvirubra to exclude S. wadsworthensis
showed merely a 15% reduction in the adherence to Caco-2
cells and no effect on the adherence to HT-29 cells (data not
shown).
Sutterella spp. Have no Effect on
Epithelial Barrier Function In vitro
In order to study the impact of Sutterella spp. on the epithelial
barrier function, we measured TER of a Caco-2 monolayer
co-cultured with the bacteria. TER of 8-day-old Caco-2 cells
(5 days after confluence) was measured at 24 h intervals
for 48 h in total. Partially differentiated Caco-2 monolayer
was used to imitate the intestinal conditions comprising of
enterocytes still in the process of maturation and prone to
changes of barrier integrity due to external stimuli (Reunanen
et al., 2015; Valenzano et al., 2015). Sutterella spp. had no
effect on the epithelial barrier function as TER values remained
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FIGURE 2 | Adherence of Sutterella spp. to porcine and human mucus and human extracellular matrix (ECM) proteins. (A) Mucus adhesion data is
presented as an average adhesion percentage of the added bacteria and error bars show the standard deviation between four technical replicates (parallel wells)
from a representative experiment. Asterisks indicate a statistically significant difference between the species in porcine mucus binding (∗∗p < 0.01, ∗∗∗p < 0.001)
and # symbol in human mucus binding (###p < 0.001). (B) Adherence to ECM proteins compared to the background binding (BSA). Fetuin as a highly glycosylated
protein was used as control for non-specific binding. Four technical replicates were used in each biological replicate and the adhesion percentages were converted
to +/− scaling depending on the statistical significance. Symbol “+” indicates a significantly higher binding as compared to the background (BSA, p < 0.05) and
symbol “−” signifies a statistically non-significant binding as compared to the background.
FIGURE 3 | Adherence of Sutterella spp. to Caco-2 (A) and HT-29 (B) cell lines at different growth stages (3, 8, or 21 days post-plating). Data is shown
as means of adhered bacteria from the added bacteria (%) and standard deviations of four technical replicates (parallel wells) from a representative experiment.
Asterisks indicate significant difference in adhesion capability between the species: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
at the same level as the values of cells treated with culture
medium (Figure 4). On the contrary, already within 24 h
B. fragilis (positive control) had greatly enhanced the monolayer
integrity, whereas E. coli (negative control) had significantly
decreased it.
S. wadsworthensis Induces a Moderate
IL-8 Response in Enterocytes
We examined the potential pro-inflammatory properties of
Sutterella spp. by incubating 10-fold dilutions of the bacteria
with HT-29 monolayer followed by measurement of IL-8 release
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TABLE 2 | Adherence of S. wadsworthensis to 8-day-old Caco-2 and HT-29
cells in the competition and displacement assays.
Assays Cell lines
Caco-2 HT-29
No competition 100% 100%
Competition by S. parvirubra 55 ± 11%∗∗∗ 52 ± 10%∗∗∗
Displacement by S. parvirubra 73 ± 5%∗ 80 ± 11%∗
The results (mean ± SD of four technical replicates from a representative
experiment) are presented as percentages compared to the adhesion of
S. wadsworthensis without competition (100%). Asterisks indicate a significantly
reduced adhesion of S. wadsworthensis. ∗p < 0.05, ∗∗∗p < 0.001.
FIGURE 4 | The effect of Sutterella spp. on transepithelial electrical
resistance (TER) of Caco-2 monolayer. E. coli was used as a negative
control and B. fragilis as a positive control. Results from a representative
experiment are shown as mean TER values (cm2) and standard deviations
of three technical replicates (parallel wells). An asterisk indicates significantly
different (∗p < 0.05) values between the bacteria-treated and the untreated
(only growth medium) Caco-2 monolayers.
from the cells. Again, E. coli and B. fragilis were used as controls,
whereas the cells incubated solely with the culture medium
functioned as a background control. For E. coli, the results of
1:10 dilution are not shown due to excess stimulation. Previously
B. fragilis has been shown not to induce an IL-8-response in
HT-29 cells (Reunanen et al., 2015). Similarly, S. parvirubra and
S. stercoricanis did not have any effect on the IL-8 production as
levels were lower than in the medium control (Figure 5A). E. coli
and S. wadsworthensis, on the other hand, induced a significant,
dose-dependent IL-8 response in the HT-29 cells, although for
S. wadsworthensis the effect was only reached with 1:10 and 1:100
dilutions.
The same assay was carried out with crude LPS preparations
of Sutterella spp. and E. coli. All three Sutterella spp. induced
an IL-8 production above the medium control level with 1:1,000
dilution but not with 1:10,000 dilution (Figure 5B). The effect
was stronger with the LPS preparation from S. wadsworthensis.
The same LPS preparations were run in SDS-PAGE gel and
visualized with silver staining to compare the LPS structures
(Supplementary Figure S1A). All Sutterella spp. differed in
their LPS polysaccharide chain profiles. The short side-chains
expressed by S. stercoricanis were clearly visible as a ladder
formation. The antigenic similarity of LPS structures between
Sutterella spp. and E. coli was tested using whole-cell lysates
and a rabbit polyclonal antiserum against E. coli LPS. The
antiserum only reacted with E. coli lysate (Supplementary Figure
S1B). Further, we compared the possible LPS differences between
Sutterella spp. and E. coli by surveying the available genomic
data for S. parvirubra and S. wadsworthensis using the NCBI
(The National Center for Biotechnology Information, USA)
database and BLAST (Basic Local Alignment Search Tool, blastp
algorithm) for genes that encode enzymes for Kdo2-lipid A
modification. We found out that Sutterella spp. lack the genes
for LpxL and LpxM acyltransferases, which are present in E. coli
(Table 3).
DISCUSSION
Our findings show that the relative abundance of Sutterella spp. is
substantial in the duodenum of adults with a decreasing gradient
toward the colon, which has not been demonstrated before.
The bile resistant and microaerophilic properties of Sutterella
spp. (Wexler et al., 1996; Greetham et al., 2004) do indeed
imply they are adapted to the physiological conditions of the
small intestine, which, compared to the colon, consist of bile
acids secreted from the bile duct, lower pH and higher levels
of antimicrobial peptides and oxygen (Donaldson et al., 2016).
The harsh environment of the small intestine naturally influences
the microbiota composition resulting in lower bacterial density
and diversity, as well as in the enrichment of certain bacteria,
such as Proteobacteria (Zoetendal et al., 2012; Cheng et al., 2013;
Li et al., 2015). According to Li et al. (2015), the abundance of
Proteobacteria in biopsies and luminal contents of the duodenum
in healthy adults varied between 33 and 39%, whereas the
proportion in the rectal biopsies and feces was merely 5–12%.
Moreover, similar to our results, they reported that Sutterella was
one of the dominant genera only in the duodenal biopsies. In this
study, we also examined whether Sutterella spp. contribute to the
dysbiotic microbiota of rCDI patients and studied their relative
abundance pre-FMT (dysbiotic state) and after a successful
FMT treatment of rCDI. Before FMT, rCDI patients have a
dysbiotic microbiota with a higher abundance of Proteobacteria
and facultative anaerobes, which are decreased to normal level
by FMT together with an increase of obligately anaerobic gut
commensals (van Nood et al., 2013). We did not observe a
statistically significant difference in the relative proportion of
Sutterella before and after FMT and, thus, the genus does not
seem to contribute to rCDI-associated dysbiosis.
In accordance with the previous studies (Mukhopadhya et al.,
2011; Hansen et al., 2013), we found no difference in the
prevalence of Sutterella spp. or S. wadsworthensis between the
healthy controls and the pediatric IBD or CeD patients. These
results reinforce the suggestion that Sutterella spp. are likely
to be commensals in the human GI tract and do not have a
role in the etiopathology of these diseases. In agreement with
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FIGURE 5 | IL-8 production in HT-29 cells induced by bacterial cell suspensions and LPS preparations. (A) IL-8 response in HT-29 cells by
S. wadsworthensis, S. parvirubra, S. stercoricanis, B. fragilis (positive control), and E. coli (negative control) with 1:10, 1:100, and 1:1,000 dilutions from OD600 nm
0.25 adjusted cell suspensions. The 1:10 dilution is not shown for E. coli due to excessive toxicity to the HT-29 cells. (B) IL-8 production induced by 1:1,000 and
1:10,000 dilutions of LPS preparations from E. coli and Sutterella spp. LPS preparations were made from the OD600 nm 0.25 normalized cell suspensions and the
dilutions were thereof. Results from the representative experiment are shown as means and standard deviations of three technical replicates (parallel wells). The
culture medium was used as a background control in both assays. An asterisk indicates a significant (∗p < 0.05) IL-8 production above the background level.
this view, Sutterella has been associated, as a sole genus from
Proteobacteria, with a healthy outcome after ileal pouch-anal
anastomosis due to UC (Tyler et al., 2013; Morgan et al., 2015).
Furthermore, a lower abundance of Sutterella in patients with
new-onset CD (Gevers et al., 2014) or non-alcoholic fatty liver
disease has been shown recently (Del Chierico et al., 2016).
The adherence of bacteria to mucus and IECs is considered
crucial in terms of colonization and interaction with the intestinal
mucosa, especially in the small intestine, where transit time
is shorter and, thus, an efficient binding ability is of greater
importance (Donaldson et al., 2016). A mucus layer, composed
of gel-forming intestinal mucin MUC2, partially or completely
covers the small intestine and the colon creating a barrier
between the epithelium and the bacterial community (Johansson
et al., 2013; Pelaseyed et al., 2014; Donaldson et al., 2016).
However, unlike the colon with a dense inner and a loose
outer layer, the mucus covering the small intestine is loose
and unattached, allowing bacteria to penetrate and interact with
IECs (Johansson et al., 2013). ECM components, on the other
hand, are located in the basal lamina providing support for
the epithelial cells and exposed to the luminal bacteria only if
the mucosal surface is disrupted (Westerlund and Korhonen,
1993).
In this study we observed that S. wadsworthensis bound
markedly better to mucus and ECM proteins than the other two
species, whereas S. parvirubra could adhere at a higher level
to differentiated enterocytes and displace S. wadsworthensis in
adhesion. Sutterella spp. adhered equally well or even better to
TABLE 3 | Comparison of Kdo2-lipid A biosynthesis enzymes between E. coli K12 and Sutterella spp.
Organism Genome accession number Enzymes needed for Kdo2-lipid A biosynthesis
LpxA LpxC LpxD LpxH LpxB LpxK WaaA LpxL LpxM
Escherichia coli K12 NC_000913 (Blattner et al., 1997) + + + + + + + + +
Sutterella wadsworthensis
2_1_59BFAA
ADMG00000000.1 (Earl et al., unpublished) + + + + + + +
Sutterella parvirubra
YIT11816
AFBQ00000000.1 (Weinstock et al., unpublished) + + + + + + +
LpxA, UDP-N-acetylglucosamine acetyltransferase; LpxC, UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase; LpxD, UDP-3-O-(3-hydroxymyrist
oyl)glucosamine N-acyltransferase; LpxH, UDP-2,3-diacylglucosamine pyrophosphohydrolase; LpxB, lipid-A-disaccharide synthase; LpxK, lipid A 4′-kinase; WaaA,
3-deoxy-D-manno-octulosonate lipid A transferase; LpxL, Kdo2-lipid IVa lauroyl-ACP acyltransferase; LpxM, Kdo2-lauroyl-lipid IVa-myristoyl-ACP acyltransferase.
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enterocytes than the well-known probiotic strain Lactobacillus
rhamnosus GG or commensal mucosa-associated bacterium
Akkermansia muciniphila by using the same assay indicating
a moderate adhesion ability (Reunanen et al., 2015). A direct
contact with the host tissue by Sutterella spp. is likely, since
the thinner mucus layer of the small intestine is discontinuous
enabling a direct interaction between the microbiota and the
IECs (Johansson et al., 2013), and considering the abundance of
these species in the duodenum. Therefore, Sutterella spp. have an
opportunity to interact actively with the host. Gut commensals
are needed to induce the steady-state Th17 differentiation
(Gaboriau-Routhiau et al., 2009; Ivanov et al., 2009; Atarashi
et al., 2015). Importantly, this immunostimulatory action was
recently shown to be dependent on the ability of bacteria to
adhere to IECs, which then cue Th17 differentiation in LP
(Atarashi et al., 2015). Consequently, by adhering to IECs
Sutterella spp. may participate in such action. We used three type
strains to examine the adherence and the immunostimulatory
abilities of the genus Sutterella and to our knowledge, this is
the first study to explore the epithelial interactions of Sutterella
spp. However, we acknowledge that further studies by using
fresh clinical isolates from patients and healthy individuals are
needed to confirm our findings on the commensal nature of
Sutterella spp.
IECs secrete a cytokine IL-8 in response to various
inflammatory stimuli activating neutrophils into the infected
mucosa (Lammers et al., 1994; Mitsuyama et al., 1994). We
observed that S. wadsworthensis caused stronger inflammatory
cascade in the enterocytes than the other two species by eliciting
an IL-8 response, although the stimulation was merely moderate
compared to the IL-8 release induced by E. coli. However, none
of Sutterella spp. had an impact on the epithelial barrier function
indicating their role as harmless bystanders. Furthermore, the
mild pro-inflammatory capacity of S. wadsworthensis without
the disruption of epithelial integrity may assist in keeping the
host’s immune system alerted at an appropriate, physiological
level. In another study, S. wadsworthensis strains isolated from
healthy controls and IBD patients induced higher levels of TNF-
α compared to E. coli in human monocytes, but no difference in
the cytokine stimulation was detected between the strains isolated
from the two groups (Mukhopadhya et al., 2011).
We found that there are differences in the pro-inflammatory
properties between Sutterella spp. as well as between Sutterella
spp. and E. coli and, thus, speculate that this could be due
to their varying LPS structures. LPS on the surface of Gram-
negative bacteria is composed of Kdo2-Lipid A (endotoxin),
core-oligosaccharide and O-antigen repeats and recognized by
the host TLR4–MD2 complex (Miller et al., 2005; Han et al.,
2013; Polissi and Sperandeo, 2014). We visualized the differences
in the LPS structure between the species by silver staining of
the SDS-PAGE separated LPS, which revealed differences in
O-antigen repeats, and by immunoblotting with an antiserum
against E. coli LPS, which did not recognize LPS from Sutterella
spp. However, the endotoxicity of LPS is more determined
by the lipid A structure, such as phosphorylation degree as
well as the number and length of acyl chains, which affects
its ligand affinity to TLR4–MD2 (Kobayashi et al., 2006; Park
et al., 2009; Han et al., 2013). The E. coli lipid A is hexa-
acylated with two phosphate groups and therefore can activate
the TLR4–Mal–MyD88 pathway making it highly virulent,
whereas the penta-acylated or monophosphorylated forms of
lipid A are 100-fold less toxic by signaling through TLR4–
TRAM–TRIF (Park et al., 2009; Herath et al., 2011; Han et al.,
2013).
We next searched the genomes of S. wadsworthensis and
S. parvirubra (NCBI database) and observed that these species
lack the genes for LpxL and LpxM, which are the enzymes
responsible for adding the secondary acyl chains (hexa-
acylation), and, consequently, are likely to carry the tetra-acylated
lipid A with reduced toxicity. Our results support this view,
since Sutterella LPS did not produce a strong IL-8 response
in the HT-29 cells in contrast to E. coli. Quite surprisingly
only E. coli and related Proteobacteria have all nine genes
needed for the complete Kdo2-lipid A biosynthesis (Opiyo et al.,
2010). Recently, it was shown that the LPS of Bacteroides dorei,
which has tetra- and penta-acylated lipid A, differs majorly
in its immunomodulation capacity from that of E. coli LPS
(Vatanen et al., 2016). The structural diversity of LPS and lipid
A among Gram-negative bacteria and Proteobacteria is wide and,
therefore, it is essential to study the host–microbe interactions of
a vast repertoire of intestinal bacteria. Our study expands such
studies to cover Sutterella spp.
It is of interest that in vitro Sutterella spp. can be successfully
grown only on solid media or in chopped meat broth, which
includes solid particles (Wexler et al., 1996; Mukhopadhya et al.,
2011; Williams et al., 2012; Hansen et al., 2013). This may
reflect their life-style in the GI track, i.e., that they are mainly
epithelium-associated bacteria. Based on our adhesion results, we
speculate that Sutterella spp. possess specific niches in the small
intestine. S. parvirubra adhered strongest to enterocytes and
showed competitiveness against S. wadsworthensis in enterocyte
binding, whereas S. wadsworthensis displayed the strongest
binding to intestinal mucus and ECM proteins. The human
GI tract can be colonized by single or multiple Sutterella
spp. (Williams et al., 2012). Considering the host–microbiota
symbiosis, it might be preferable that S. parvirubra with low pro-
inflammatory capacity is tissue-associated and S. wadsworthensis
with the ability of inducing inflammation cascades occupies the
mucus layer. Proteobacteria most likely are involved in the pro-
inflammatory changes leading to dysbiosis in the human GI
tract (Mukhopadhya et al., 2012; Shin et al., 2015). Yet, it is the
largest and most diverse phylum comprising, for instance, IBD
associated Enterobacteriaceae and other medically important
gammaproteobacteria, as well as Burkholderiales order belonging
to Betaproteobacteria, which have not been linked directly to any
GI diseases (Mukhopadhya et al., 2012). However, Sutterella spp.
do not seem to contribute to a dysbiotic state of the gut, but
instead their presence, especially in the duodenum, and ability
to adhere to IECs indicate them to be mutualistic keeping the
immune system alerted.
In conclusion, our results indicate that the members of the
genus Sutterella are widely prevalent commensals with IEC-
adhesion and mild pro-inflammatory capacities in the human GI
tract.
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